These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 17449988

  • 1. Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study.
    Portenoy RK, Farrar JT, Backonja MM, Cleeland CS, Yang K, Friedman M, Colucci SV, Richards P.
    Clin J Pain; 2007 May; 23(4):287-99. PubMed ID: 17449988
    [Abstract] [Full Text] [Related]

  • 2. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.
    Likar R, Kayser H, Sittl R.
    Clin Ther; 2006 Jun; 28(6):943-52. PubMed ID: 16860176
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
    Hartrick C, Van Hove I, Stegmann JU, Oh C, Upmalis D.
    Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: a multicenter, open-label, uncontrolled, prospective, observational clinical study.
    Muriel C, Failde I, Micó JA, Neira M, Sánchez-Magro I.
    Clin Ther; 2005 Apr; 27(4):451-62. PubMed ID: 15922818
    [Abstract] [Full Text] [Related]

  • 11. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM, Messina J, Xie F, Hale M.
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer pain patients, starting with 5 mg tablets.
    Koizumi W, Toma H, Watanabe K, Katayama K, Kawahara M, Matsui K, Takiuchi H, Yoshino K, Araki N, Kodama K, Kimura H, Kono I, Hasegawa H, Hatanaka K, Hiraga K, Takeda F.
    Jpn J Clin Oncol; 2004 Oct; 34(10):608-14. PubMed ID: 15591459
    [Abstract] [Full Text] [Related]

  • 13. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.
    Meissner W, Leyendecker P, Mueller-Lissner S, Nadstawek J, Hopp M, Ruckes C, Wirz S, Fleischer W, Reimer K.
    Eur J Pain; 2009 Jan; 13(1):56-64. PubMed ID: 18762438
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacological approach to chronic visceral pain. Focus on oxycodone controlled release: an open multicentric study.
    Liguori S, Gottardi M, Micheletto G, Bruno L.
    Eur Rev Med Pharmacol Sci; 2010 Mar; 14(3):185-90. PubMed ID: 20391956
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department.
    Miner JR, Moore J, Gray RO, Skinner L, Biros MH.
    Acad Emerg Med; 2008 Dec; 15(12):1234-40. PubMed ID: 18945240
    [Abstract] [Full Text] [Related]

  • 19. Clinical outcomes during opioid titration following initiation with or conversion to Remoxy®, an extended-release formulation of oxycodone.
    Roland CL, Setnik B, Cleveland JM, Brown DA.
    Postgrad Med; 2011 Jul; 123(4):148-59. PubMed ID: 21680999
    [Abstract] [Full Text] [Related]

  • 20. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
    Peniston JH, Gould E.
    Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.